JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gerald D. Buckberg
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castellá, M.
Right arrow Articles by Ignarro, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castellá, M.
Right arrow Articles by Ignarro, L. J.
Related Collections
Right arrow Myocardial protection

J Thorac Cardiovasc Surg 2002;124:1113-1121
© 2002 The American Association for Thoracic Surgery


Cardiopulmonary Support and Physiology (CSP)

Myocyte and endothelial effects of preconditioning the jeopardized heart by inhibiting Na+/H+ exchange

Manuel Castellá, MDa, Gerald D. Buckberg, MDa, Zhongtuo Tan, PhDa, Louis J. Ignarro, PhDb

From the Department of Surgery, Division of Cardiothoracic Surgery,a and the Department of Physiology,b University of California, Los Angeles, School of Medicine, Los Angeles, Calif.

Received for publication Dec 18, 2001. Revisions requested Jan 22, 2002; revisions received March 29, 2002. Accepted for publication April 8, 2002. Address for reprints: Gerald D. Buckberg, MD, Division of Cardiothoracic Surgery, 62-258 Center for the Health Sciences, Los Angeles, CA 90095-1701 (E-mail: gbuckberg{at}mednet.ucla.edu).

Objectives: The preconditioning effects of the adjunctive, cardiac-specific sodium-hydrogen ion exchange inhibitor cariporide (cariporide mesilate, HOE 642) were studied in hearts subjected to 30 minutes of normothermic ischemia and reperfusion to assess myocardial and endothelial changes.
Methods: Sixteen Yorkshire-Duroc pigs (27-34 kg) receiving cardiopulmonary bypass underwent either cardiopulmonary bypass alone (control, n = 4) or 30 minutes of normothermic ischemia, followed by 30 minutes of blood reperfusion (n = 12). Six hearts were treated with 5 mg/kg cariporide administered intravenously 15 minutes before ischemia.
Results: Cardiopulmonary bypass alone caused no changes. Conversely, 30 minutes of global normothermic ischemia caused 33% mortality and, in survivors, depression of left ventricular function to 22% ± 6% of baseline preload recruitable stroke work and increased creatine kinase MB by 406% (88 ± 13 U/L), conjugated dienes by 17% (161 ± 0.2 AU/mL), and myeloperoxidase activity by 297% (0.036 ± 0.005 U/g). Myocardial edema developed (3.5% water gain). Coronary sinus endothelin 1 increased by 111% (2.05 ± 0.38 pg/mL), and nitric oxide production decreased by 10%. These adverse effects were limited by pretreatment with cariporide, which allowed complete survival and restored preload recruitable stroke work to 78% ± 11%. Measurements of creatine kinase MB, conjugated dienes, myeloperoxidase, water, and endothelin 1 returned to baseline values, and nitric oxide production was accentuated 3-fold.
Conclusions: These observations show that adjunctive pretreatment with cariporide delays myocardial and endothelial injury during ischemia and reperfusion, limits oxygen-derived radical injury, restores function, reduces edema, and preserves endothelin and nitric oxide balance at normal values. The myeloperoxidase changes show that less white blood cell adherence supports reduced reperfusion endothelial damage.




This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
G. Bolotin, J. Raman, U. Williams, E. Bacha, M. Kocherginsky, and V. Jeevanandam
Glutamine Improves Myocardial Function Following Ischemia-Reperfusion Injury
Asian Cardiovasc Thorac Ann, December 1, 2007; 15(6): 463 - 467.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Castella, G. D. Buckberg, and Z. Tan
Neurologic Preservation by Na+-H+ Exchange Inhibition Prior to 90 Minutes of Hypothermic Circulatory Arrest
Ann. Thorac. Surg., February 1, 2005; 79(2): 646 - 654.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Kevelaitis, A. A. Qureshi, C. Mouas, F. Marotte, S. Kevelaitiene, M. Avkiran, and P. Menasche
Na+/H+ exchange inhibition in hypertrophied myocardium subjected to cardioplegic arrest: an effective cardioprotective approach
Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 111 - 116.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. D. Buckberg
Stroke and extra-cardiac perfusion: new vantage points in brain protection
Eur. J. Cardiothorac. Surg., December 1, 2004; 26(Suppl_1): S62 - S67.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Vinten-Johansen and R. M. Mentzer Jr
Attenuation of postcardioplegia injury with inhibitors of the sodium-hydrogen exchanger
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1265 - 1267.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Castella, G. D. Buckberg, S. Saleh, Z. Tan, and L. J. Ignarro
A new role for cardioplegic buffering: should acidosis or calcium accumulation be counteracted to salvage jeopardized hearts?
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1442 - 1448.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The American Association for Thoracic Surgery.